Neonatal drug withdrawal syndrome: Cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 101, Issue 1, 2016, Pages F26-F30

  Davies, Hilary ^a   Gilbert, Ruth ^b   Johnson, Kathryn ^c   Petersen, Irene ^a   Nazareth, Irwin ^a   O'Donnell, Melissa ^d   Guttmann, Astrid ^e   Gonzalez Izquierdo, Arturo ^f  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; BIRTH WEIGHT; CANADA; COHORT ANALYSIS; DELIVERY; FEMALE; HUMAN; LENGTH OF STAY; LIVE BIRTH; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN; NEWBORN DISEASE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED KINGDOM; UNITED STATES; WITHDRAWAL SYNDROME; ENGLAND; HOSPITALIZATION; MALE; NEONATAL ABSTINENCE SYNDROME; ONTARIO; PREGNANCY; STATISTICS AND NUMERICAL DATA; WESTERN AUSTRALIA;

ADULT; BIRTH WEIGHT; COHORT STUDIES; ENGLAND; FEMALE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; LIVE BIRTH; MALE; MATERNAL AGE; NEONATAL ABSTINENCE SYNDROME; ONTARIO; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDIES; UNITED STATES; WESTERN AUSTRALIA;

EID: 84958760827     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2015-308948     Document Type: Article

References (34)

1. Madgula RM, Groshkova T, Mayet S. Illicit drug use in pregnancy: effects and management. Expert Rev Obstet Gynecol 2011;6:179-92.
2. O'Donnell M, Nassar N, Leonard H, et al. Increasing prevalence of neonatal withdrawal syndrome: population study of maternal factors and child protection involvement. Pediatrics 2009;123:e614-21.
3. Doberczak TM, Kandall SR, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 1991;118:933-7.
4. Hudak ML, Tan RC, Frattarelli, et al. Neonatal drug withdrawal. Pediatrics 2012;129:e540-60.
5. Klinger G, Merlob P. Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome. Isr J Psychiatry Relat Sci 2008;45:107-13.
6. Lloyd DJ, Mysercough EJ. Neonatal Abstinence Syndrome A New Intervention: A Community Based, Structured Health Visitor Assessment [Internet]. Scottish Executive Social Research Substance Misuse Research Programme; 2006. http://www.scotland.gov.uk/Resource/Doc/146679/0038382.pdf (accessed Jan 2015).
7. O'Grady MJ, Hopewell J, White MJ. Management of neonatal abstinence syndrome: a national survey and review of practice. Arch Dis Child Fetal Neonatal Ed 2009;94: F249-52.
8. Johnson K, Greenough A, Gerada C. Maternal drug use and length of neonatal unit stay. Addict Abingdon Engl 2003;98:785-9.
9. Abdel-Latief ME, Oei J, Craig F, et al., on behalf of the NSW and ACT NAS Epidemiology Group. Profile of infants born to drug-using mothers: a state-wide audit. J Paediatr Child Health 2013;49:E80-6.
10. Kahila H, Gissler M, Sarkola T, et al. Maternal welfare, morbidity and mortality 6-15 years after a pregnancy complicated by alcohol and substance abuse: a register-based case-control follow-up study of 524 women. Drug Alcohol Depend 2010;111:215-21.
11. Health and Social Care Information Centre. Hospital Episode Statistics [Internet]. 2012. http://www.hscic.gov.uk/hes (accessed Jan 2015).
12. World Health Organisation. International Classification of Diseases and Related Health Problems, 10th Revision. Geneva: WHO, 2010.
13. Patrick SW, Schumacher RE, Benneyworth BD, et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA J Am Med Assoc 2012;307:1934-40.
14. Turner SD, Gomes T, Camacho X, et al. Neonatal opioid withdrawal and antenatal opioid prescribing. Can Med Assoc Open Access J 2015;3:E55-61.
15. Brocklehurst P, Hardy P, Hollowell J, et al., Birthplace in England Collaborative Group. Perinatal and maternal outcomes by planned place of birth for healthy women with low risk pregnancies: the Birthplace in England national prospective cohort study. BMJ 2011;343:d7400.
16. Murray J, Saxena S, Modi N, et al. Quality of routine hospital birth records and the feasibility of their use for creating birth cohorts. J Public Health Oxf Engl 2013;35:298-307.
17. MHASEF Research Team. The mental health of children and youth in Ontario: a baseline scorecard. Toronto, ON: Institute for Clinical Evaluative Sciences, 2015.
18. NHS foundation trust directory-GOV.UK. https://www.gov.uk/government/publications/nhs-foundation-trust-directory/nhs-foundation-trust-directory (accessed Jan 2015).
19. Spiegelhalter DJ. Funnel plots for comparing institutional performance. Stat Med 2005;24:1185-202.
20. Health and Social Care Information Centre. Strategic Health Authorities. 2013. http://www.datadictionary.nhs.uk/data-dictionary/nhs-business-definitions/s/strategic-health-Authority-de.asp?shownav=1 (accessed Jan 2015).
21. Department of Health. Drug Misuse and Dependence-Guidelines on Clinical Management [Internet]. HM Stationary Office, 1999. http://www.dldocs.stir.ac.uk/documents/clinical.pdf
22. House of Commons Home Affairs Committee. Drugs: new psychoactive substances and prescription drugs. Twelfth Report of Session 2013-14.2013.
23. National Treatment Agency for Substance Misuse. Women in drug treatment: what the latest figures reveal [Internet]. NTA; 2010. http://www.nta.nhs.uk/uploads/ntawomenintreatment22march2010.pdf (accessed Jan 2015).
24. Drugscope. Drug treatment at the crossroads. What it's for, where it's at and how to make it even better [Internet]. 2009. http://www.drugscope.org.uk/Resources/Drugscope/Documents/PDF/Good%20Practice/Drugtreatmentatthecrossroads.pdf (accessed Jan 2015).
25. Tolia VN, Patrick SW, Bennett MM, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med 2015;372:2118-26.
26. Kuehn BM. Opioid prescriptions soar. JAMA 2007;297:249-51.
27. Manchikanti L, Helm S, Fellows B, et al. Opioid epidemic in the United States. Pain Physician 2012;15(3 Suppl):ES9-38.
28. National Institute of Drug Abuse. DrugFacts: Prescription and over-the-counter medications. 2014. http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&source= web&cd=1&ved=0CCoQFjAA&url=http%3A%2F%2Fwww.drugabuse.gov% 2Fpublications%2Fdrugfacts%2Fprescription-over-counter-medications&ei=-NhlVPrVJM3taO3zgLAK&usg=AFQjCNF4ED-GJAumPcyCYDcjAEQJJqkLCQ&bvm=bv. 79142246,bs.1,d.ZWU (accessed Jan 2015).
29. Stannard C. Opioids in the UK: what's the problem? BMJ 2013;347:f5108.
30. National Institute for Clinical Excellence. Quality Standards Programme NICE cost impact and commissioning assessment: quality standard for specialist neonatal care [Internet]. 2008. http://www.nice.org.uk/guidance/qs4/resources/qs4-specialistneonatal-care-cost-impact-And-commissioning-Assessment2 (accessed Jan 2015).
31. Hay G, Rael dos Santos A, Millar T. National and Regional Estimates of the Prevalence of Opiate and/or Crack Cocaine Use 2010-2011: A Summary of Key Findings. [Internet]. National Treatment Agency for Substance Misuse. 2013. http://www.nta.nhs.uk/uploads/prevalencesummary2013v1.pdf (accessed Jan 2015).
32. Bagley SM, Wachman EM, Holland E, et al. Review of the assessment and management of neonatal abstinence syndrome. Addict Sci Clin Pr 2014;9:19.
33. Osborn DA, Jeffery HE, Cole MJ. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2010;(10):CD002059.
34. Leeds Health Pathways. Neonatal Abstinence Syndrome (last reviewed 12/05/2014). 2005.